What is SION's operating income?

SION (SION) reported operating income of -$29.6M in Q1 2026.

How has SION's operating income changed year-over-year?

SION's operating income decreased by 50.6% year-over-year, from -$19.66M to -$29.6M.

What does operating income mean?

Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

SION SION Operating Income

Operating Income at other companies

Vertex PharmaceuticalsVRTX

$1.14B+80.6%

AbbVieABBV

$3.99B+6.9%

Septerna, Inc.SEPN

-$13.3M+48.7%

BioCryst PharmaceuticalsBCRX

-$701.6M-3,405%

Denali Therapeutics Inc.DNLI

-$137.36M+5.6%

Neurocrine BiosciencesNBIX

$193.4M+719%

Other financials

Income statement

See full

Net income-$26.8M-62.5%

EPS (diluted)-$0.60+3.2%

Balance sheet

See full

Cash & equivalents$64.3M-23.2%

Total debt$8.4M-11.8%

Total equity$288.2M-18.1%

Total assets$305.0M-17.5%

Cash flow

See full

Operating cash flow-$21.8M-34.1%

CapEx--100%

Free cash flow-$21.8M-33.4%

Valuation

See full

Market cap$1.8B—

Enterprise value$1.74B—

Returns & leverage

See full

Return on equity-26.7%—

Debt / equity0×0.0×

Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SION's operating income?: SION (SION) reported operating income of -$29.6M in Q1 2026.
How has SION's operating income changed year-over-year?: SION's operating income decreased by 50.6% year-over-year, from -$19.66M to -$29.6M.
What does operating income mean?: Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.